ANNALS OF THE RHEUMATIC DISEASES

医学 风湿病学

  • 影响指数:27.945
  • 中科院分区:医学 1区[Top] 医学 1 区
  • 审稿周期:平均1.62月
  • 自引率:15.3%
  • 录取率:22.78%
  • ISSN:2190-572X
  • 发刊频率:暂无数据
  • 年文章数:454
  • 国人占比:4.87%
  • 期刊网址:点击查看
  • 研究方向:类风湿性关节炎;风湿病;自身免疫性疾病;骨关节炎;免疫
  • 期刊攻略
  • IF变化趋势
  • 期刊占比
  • 最新文章

期刊简介

3 BIOTECH杂志暂不明确行业,暂不明确子行业的级别不明杂志

收稿要求

暂无数据

建议

杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。

Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic component.

DOI:10.1136/annrheumdis-2022-222460

发表时间:2022 Jun 26

作者:Shirai Y;Nakanishi Y;Suzuki A;Konaka H;Nishikawa R;Sonehara K;Namba S;Tanaka H;Masuda T;Yaga M;Satoh S;Izumi M;Mizuno Y;Jo T;Maeda Y;Nii T;Oguro-Igashira E;Biobank Japan Project.;Morisaki T;Kamatani Y;Nakayamada S;Nishigori C;Tanaka Y;Takeda Y;Yamamoto K;Kumanogoh A;Okada Y

Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-α-mediated ERK1/2 and JAK-STAT1 pathways.

DOI:10.1136/ard-2022-222605

发表时间:2022 Jun 27

作者:Qin Y;Cai ML;Jin HZ;Huang W;Zhu C;Bozec A;Huang J;Chen Z

Serum urate outcomes of treat-to-target urate lowering treatment: results of a nationwide cohort study from 1997 to the COVID-19 pandemic using data from the Clinical Practice Research Datalink.

DOI:10.1136/ard-2022-222668

发表时间:2022 Jun 30

作者:Abhishek A;Cipolletta E;Nakafero G;Avery AJ;Mamas M;Tata LJ

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial.

DOI:10.1136/ard-2022-222608

发表时间:2022 Jul 4

作者:van der Heijde D;Baraliakos X;Sieper J;Deodhar A;Inman RD;Kameda H;Zeng X;Sui Y;Bu X;Pangan AL;Wung P;Song IH

Leflunomide versus azathioprine for maintenance therapy of lupus nephritis: a prospective, multicentre, randomised trial and long-term follow-up.

DOI:10.1136/ard-2022-222486

发表时间:2022 Jul 4

作者:Fu Q;Wu C;Dai M;Wang S;Xu J;Dai L;Li Z;He L;Zhu X;Sun L;Lu L;Bao C

公众号